Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.20 |
| Open | 5.68 |
| Bid | 5.14 x 500 |
| Ask | 5.17 x 100 |
| Day's Range | 5.04 - 5.77 |
| 52 Week Range | 4.71 - 12.43 |
| Volume | |
| Avg. Volume | 2,098,319 |
| Market Cap | 739.408M |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of 82.35% and 8.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals...
- Insider Monkey
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]
© 2024 Yahoo. All rights reserved.